Literature DB >> 19026498

In vitro characterisation of koala Chlamydia pneumoniae: morphology, inclusion development and doubling time.

Candice M Mitchell1, Sarah A Mathews, Christina Theodoropoulos, Peter Timms.   

Abstract

Chlamydia pneumoniae is a common human and animal pathogen associated with upper and lower respiratory tract infections. Of the animal C. pneumoniae isolates, the koala nasal isolate (LPCoLN) is by far the best genetically characterised. This current study was designed to characterise the morphology and developmental events for the LPCoLN isolate, and our results showed several striking in vitro growth differences when compared to the human isolate, AR39. The LPCoLN inclusion size and morphology was distinct from AR39, and a much faster doubling time (3.4-4.9h versus 5.9-8.7h doubling time) was observed when grown in HEp-2 cell monolayers. Confocal and electron microscopy of LPCoLN confirmed large (9-30 microm in diameter) inclusions, that were heterogeneously shaped, compared to the small (5-9 microm in diameter), uniformly shaped inclusions of AR39. The morphology of the LPCoLN elementary body was round, and had a narrow or nonexistent periplasmic space, compared to the 'pear-shaped' morphology of AR39 EBs. While both isolates showed evidence of inclusion fusion, the level of fusion was much higher for LPCoLN (100%) compared to AR39 (30-40%). Our findings have provided new insights and identified key differences in the in vitro doubling time, size and morphology of an animal C. pneumoniae isolate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026498     DOI: 10.1016/j.vetmic.2008.10.008

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

Review 1.  Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Authors:  Wilhelmina M Huston; Christopher J Barker; Anu Chacko; Peter Timms
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

2.  Evidence that human Chlamydia pneumoniae was zoonotically acquired.

Authors:  G S A Myers; S A Mathews; M Eppinger; C Mitchell; K K O'Brien; O R White; F Benahmed; R C Brunham; T D Read; J Ravel; P M Bavoil; P Timms
Journal:  J Bacteriol       Date:  2009-09-11       Impact factor: 3.490

3.  Comparison of koala LPCoLN and human strains of Chlamydia pneumoniae highlights extended genetic diversity in the species.

Authors:  Candice M Mitchell; Kelley M Hovis; Patrik M Bavoil; Garry S A Myers; Jose A Carrasco; Peter Timms
Journal:  BMC Genomics       Date:  2010-07-21       Impact factor: 3.969

4.  Phylogenetic analysis of human Chlamydia pneumoniae strains reveals a distinct Australian indigenous clade that predates European exploration of the continent.

Authors:  Eileen Roulis; Nathan Bachmann; Michael Humphrys; Garry Myers; Wilhelmina Huston; Adam Polkinghorne; Peter Timms
Journal:  BMC Genomics       Date:  2015-12-22       Impact factor: 3.969

5.  Chlamydia Serine Protease Inhibitor, targeting HtrA, as a New Treatment for Koala Chlamydia infection.

Authors:  Amba Lawrence; Tamieka Fraser; Amber Gillett; Joel D A Tyndall; Peter Timms; Adam Polkinghorne; Wilhelmina M Huston
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

6.  A targeted approach to investigating immune genes of an iconic Australian marsupial.

Authors:  Luke W Silver; Yuanyuan Cheng; Bonnie L Quigley; Amy Robbins; Peter Timms; Carolyn J Hogg; Katherine Belov
Journal:  Mol Ecol       Date:  2022-05-17       Impact factor: 6.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.